APA aipamena

Levitan, B., Markowitz, M., Turkoz, I., Fu, D., Gopal, S., & Alphs, L. (2016). Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia. Int Clin Psychopharmacol.

Chicago Style aipamena

Levitan, Bennett, Michael Markowitz, Ibrahim Turkoz, Dong-Jing Fu, Srihari Gopal, and Larry Alphs. "Benefit–risk Assessment of Paliperidone Oral Extended-release Tablet Versus Monthly Injectable for Maintenance Treatment of Schizophrenia." Int Clin Psychopharmacol 2016.

MLA aipamena

Levitan, Bennett, et al. "Benefit–risk Assessment of Paliperidone Oral Extended-release Tablet Versus Monthly Injectable for Maintenance Treatment of Schizophrenia." Int Clin Psychopharmacol 2016.